EDT — Spectral Medical Income Statement
0.000.00%
Last trade - 00:00
- CA$133.75m
- CA$139.36m
- CA$1.60m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.87 | 2.1 | 2.05 | 1.67 | 1.6 |
Cost of Revenue | |||||
Gross Profit | 2.22 | 1.47 | 1.22 | 0.983 | 0.662 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.73 | 11.2 | 10.8 | 9.26 | 17.1 |
Operating Profit | -4.86 | -9.1 | -8.79 | -7.6 | -15.5 |
Net Income Before Taxes | -4.86 | -9.1 | -8.79 | -7.6 | -15.5 |
Net Income After Taxes | -4.86 | -9.1 | -8.79 | -7.6 | -15.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.86 | -9.1 | -8.79 | -11.3 | -15.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.86 | -9.1 | -8.79 | -11.3 | -15.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.022 | -0.039 | -0.035 | -0.028 | -0.054 |